Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilar Testing and Development Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Effector Binding
1.2.3 ELISA
1.2.4 Kinetic Binding Assays
1.2.5 ADCC & CDC Cell-Based Assays
1.3 Market by Application
1.3.1 Global Biosimilar Testing and Development Services Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 PK assay
1.3.3 Tiered Immunogenicity testing
1.3.4 NAb assays
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biosimilar Testing and Development Services Market Perspective (2018-2033)
2.2 Biosimilar Testing and Development Services Growth Trends by Region
2.2.1 Global Biosimilar Testing and Development Services Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Biosimilar Testing and Development Services Historic Market Size by Region (2018-2023)
2.2.3 Biosimilar Testing and Development Services Forecasted Market Size by Region (2024-2033)
2.3 Biosimilar Testing and Development Services Market Dynamics
2.3.1 Biosimilar Testing and Development Services Industry Trends
2.3.2 Biosimilar Testing and Development Services Market Drivers
2.3.3 Biosimilar Testing and Development Services Market Challenges
2.3.4 Biosimilar Testing and Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimilar Testing and Development Services Players by Revenue
3.1.1 Global Top Biosimilar Testing and Development Services Players by Revenue (2018-2023)
3.1.2 Global Biosimilar Testing and Development Services Revenue Market Share by Players (2018-2023)
3.2 Global Biosimilar Testing and Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biosimilar Testing and Development Services Revenue
3.4 Global Biosimilar Testing and Development Services Market Concentration Ratio
3.4.1 Global Biosimilar Testing and Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Testing and Development Services Revenue in 2022
3.5 Biosimilar Testing and Development Services Key Players Head office and Area Served
3.6 Key Players Biosimilar Testing and Development Services Product Solution and Service
3.7 Date of Enter into Biosimilar Testing and Development Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilar Testing and Development Services Breakdown Data by Type
4.1 Global Biosimilar Testing and Development Services Historic Market Size by Type (2018-2023)
4.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2024-2033)
5 Biosimilar Testing and Development Services Breakdown Data by Application
5.1 Global Biosimilar Testing and Development Services Historic Market Size by Application (2018-2023)
5.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Biosimilar Testing and Development Services Market Size (2018-2033)
6.2 North America Biosimilar Testing and Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Biosimilar Testing and Development Services Market Size by Country (2018-2023)
6.4 North America Biosimilar Testing and Development Services Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biosimilar Testing and Development Services Market Size (2018-2033)
7.2 Europe Biosimilar Testing and Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Biosimilar Testing and Development Services Market Size by Country (2018-2023)
7.4 Europe Biosimilar Testing and Development Services Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biosimilar Testing and Development Services Market Size (2018-2033)
8.2 Asia-Pacific Biosimilar Testing and Development Services Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biosimilar Testing and Development Services Market Size (2018-2033)
9.2 Latin America Biosimilar Testing and Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Biosimilar Testing and Development Services Market Size by Country (2018-2023)
9.4 Latin America Biosimilar Testing and Development Services Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosimilar Testing and Development Services Market Size (2018-2033)
10.2 Middle East & Africa Biosimilar Testing and Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Detail
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific Biosimilar Testing and Development Services Introduction
11.1.4 Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2018-2023)
11.1.5 Eurofins Scientific Recent Development
11.2 SGS
11.2.1 SGS Company Detail
11.2.2 SGS Business Overview
11.2.3 SGS Biosimilar Testing and Development Services Introduction
11.2.4 SGS Revenue in Biosimilar Testing and Development Services Business (2018-2023)
11.2.5 SGS Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Detail
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Biosimilar Testing and Development Services Introduction
11.3.4 Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2018-2023)
11.3.5 Charles River Laboratories Recent Development
11.4 Pharmaceutical Product Development
11.4.1 Pharmaceutical Product Development Company Detail
11.4.2 Pharmaceutical Product Development Business Overview
11.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Introduction
11.4.4 Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2018-2023)
11.4.5 Pharmaceutical Product Development Recent Development
11.5 Exova
11.5.1 Exova Company Detail
11.5.2 Exova Business Overview
11.5.3 Exova Biosimilar Testing and Development Services Introduction
11.5.4 Exova Revenue in Biosimilar Testing and Development Services Business (2018-2023)
11.5.5 Exova Recent Development
11.6 Source BioScience
11.6.1 Source BioScience Company Detail
11.6.2 Source BioScience Business Overview
11.6.3 Source BioScience Biosimilar Testing and Development Services Introduction
11.6.4 Source BioScience Revenue in Biosimilar Testing and Development Services Business (2018-2023)
11.6.5 Source BioScience Recent Development
11.7 Intertek Group
11.7.1 Intertek Group Company Detail
11.7.2 Intertek Group Business Overview
11.7.3 Intertek Group Biosimilar Testing and Development Services Introduction
11.7.4 Intertek Group Revenue in Biosimilar Testing and Development Services Business (2018-2023)
11.7.5 Intertek Group Recent Development
11.8 Medistri
11.8.1 Medistri Company Detail
11.8.2 Medistri Business Overview
11.8.3 Medistri Biosimilar Testing and Development Services Introduction
11.8.4 Medistri Revenue in Biosimilar Testing and Development Services Business (2018-2023)
11.8.5 Medistri Recent Development
11.9 Pace Analytical Services
11.9.1 Pace Analytical Services Company Detail
11.9.2 Pace Analytical Services Business Overview
11.9.3 Pace Analytical Services Biosimilar Testing and Development Services Introduction
11.9.4 Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2018-2023)
11.9.5 Pace Analytical Services Recent Development
11.10 Sigma-Aldrich
11.10.1 Sigma-Aldrich Company Detail
11.10.2 Sigma-Aldrich Business Overview
11.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Introduction
11.10.4 Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2018-2023)
11.10.5 Sigma-Aldrich Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Biosimilar Testing and Development Services Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Effector Binding
Table 3. Key Players of ELISA
Table 4. Key Players of Kinetic Binding Assays
Table 5. Key Players of ADCC & CDC Cell-Based Assays
Table 6. Global Biosimilar Testing and Development Services Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Biosimilar Testing and Development Services Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Biosimilar Testing and Development Services Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Biosimilar Testing and Development Services Market Share by Region (2018-2023)
Table 10. Global Biosimilar Testing and Development Services Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Biosimilar Testing and Development Services Market Share by Region (2024-2033)
Table 12. Biosimilar Testing and Development Services Market Trends
Table 13. Biosimilar Testing and Development Services Market Drivers
Table 14. Biosimilar Testing and Development Services Market Challenges
Table 15. Biosimilar Testing and Development Services Market Restraints
Table 16. Global Biosimilar Testing and Development Services Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Biosimilar Testing and Development Services Market Share by Players (2018-2023)
Table 18. Global Top Biosimilar Testing and Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Testing and Development Services as of 2022)
Table 19. Ranking of Global Top Biosimilar Testing and Development Services Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Biosimilar Testing and Development Services Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Biosimilar Testing and Development Services Product Solution and Service
Table 23. Date of Enter into Biosimilar Testing and Development Services Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biosimilar Testing and Development Services Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2018-2023)
Table 27. Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2024-2033)
Table 29. Global Biosimilar Testing and Development Services Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Biosimilar Testing and Development Services Revenue Market Share by Application (2018-2023)
Table 31. Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Biosimilar Testing and Development Services Revenue Market Share by Application (2024-2033)
Table 33. North America Biosimilar Testing and Development Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Biosimilar Testing and Development Services Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Biosimilar Testing and Development Services Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Biosimilar Testing and Development Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Biosimilar Testing and Development Services Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Biosimilar Testing and Development Services Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Biosimilar Testing and Development Services Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Biosimilar Testing and Development Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Biosimilar Testing and Development Services Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Biosimilar Testing and Development Services Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Biosimilar Testing and Development Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2024-2033) & (US$ Million)
Table 48. Eurofins Scientific Company Detail
Table 49. Eurofins Scientific Business Overview
Table 50. Eurofins Scientific Biosimilar Testing and Development Services Product
Table 51. Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2018-2023) & (US$ Million)
Table 52. Eurofins Scientific Recent Development
Table 53. SGS Company Detail
Table 54. SGS Business Overview
Table 55. SGS Biosimilar Testing and Development Services Product
Table 56. SGS Revenue in Biosimilar Testing and Development Services Business (2018-2023) & (US$ Million)
Table 57. SGS Recent Development
Table 58. Charles River Laboratories Company Detail
Table 59. Charles River Laboratories Business Overview
Table 60. Charles River Laboratories Biosimilar Testing and Development Services Product
Table 61. Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2018-2023) & (US$ Million)
Table 62. Charles River Laboratories Recent Development
Table 63. Pharmaceutical Product Development Company Detail
Table 64. Pharmaceutical Product Development Business Overview
Table 65. Pharmaceutical Product Development Biosimilar Testing and Development Services Product
Table 66. Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2018-2023) & (US$ Million)
Table 67. Pharmaceutical Product Development Recent Development
Table 68. Exova Company Detail
Table 69. Exova Business Overview
Table 70. Exova Biosimilar Testing and Development Services Product
Table 71. Exova Revenue in Biosimilar Testing and Development Services Business (2018-2023) & (US$ Million)
Table 72. Exova Recent Development
Table 73. Source BioScience Company Detail
Table 74. Source BioScience Business Overview
Table 75. Source BioScience Biosimilar Testing and Development Services Product
Table 76. Source BioScience Revenue in Biosimilar Testing and Development Services Business (2018-2023) & (US$ Million)
Table 77. Source BioScience Recent Development
Table 78. Intertek Group Company Detail
Table 79. Intertek Group Business Overview
Table 80. Intertek Group Biosimilar Testing and Development Services Product
Table 81. Intertek Group Revenue in Biosimilar Testing and Development Services Business (2018-2023) & (US$ Million)
Table 82. Intertek Group Recent Development
Table 83. Medistri Company Detail
Table 84. Medistri Business Overview
Table 85. Medistri Biosimilar Testing and Development Services Product
Table 86. Medistri Revenue in Biosimilar Testing and Development Services Business (2018-2023) & (US$ Million)
Table 87. Medistri Recent Development
Table 88. Pace Analytical Services Company Detail
Table 89. Pace Analytical Services Business Overview
Table 90. Pace Analytical Services Biosimilar Testing and Development Services Product
Table 91. Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2018-2023) & (US$ Million)
Table 92. Pace Analytical Services Recent Development
Table 93. Sigma-Aldrich Company Detail
Table 94. Sigma-Aldrich Business Overview
Table 95. Sigma-Aldrich Biosimilar Testing and Development Services Product
Table 96. Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2018-2023) & (US$ Million)
Table 97. Sigma-Aldrich Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosimilar Testing and Development Services Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Biosimilar Testing and Development Services Market Share by Type: 2022 VS 2033
Figure 3. Effector Binding Features
Figure 4. ELISA Features
Figure 5. Kinetic Binding Assays Features
Figure 6. ADCC & CDC Cell-Based Assays Features
Figure 7. Global Biosimilar Testing and Development Services Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Biosimilar Testing and Development Services Market Share by Application: 2022 VS 2033
Figure 9. PK assay Case Studies
Figure 10. Tiered Immunogenicity testing Case Studies
Figure 11. NAb assays Case Studies
Figure 12. Biosimilar Testing and Development Services Report Years Considered
Figure 13. Global Biosimilar Testing and Development Services Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Biosimilar Testing and Development Services Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Biosimilar Testing and Development Services Market Share by Region: 2022 VS 2033
Figure 16. Global Biosimilar Testing and Development Services Market Share by Players in 2022
Figure 17. Global Top Biosimilar Testing and Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Testing and Development Services as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Biosimilar Testing and Development Services Revenue in 2022
Figure 19. North America Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Biosimilar Testing and Development Services Market Share by Country (2018-2033)
Figure 21. United States Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Biosimilar Testing and Development Services Market Share by Country (2018-2033)
Figure 25. Germany Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Biosimilar Testing and Development Services Market Share by Region (2018-2033)
Figure 33. China Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Biosimilar Testing and Development Services Market Share by Country (2018-2033)
Figure 41. Mexico Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Biosimilar Testing and Development Services Market Share by Country (2018-2033)
Figure 45. Turkey Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Biosimilar Testing and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Eurofins Scientific Revenue Growth Rate in Biosimilar Testing and Development Services Business (2018-2023)
Figure 48. SGS Revenue Growth Rate in Biosimilar Testing and Development Services Business (2018-2023)
Figure 49. Charles River Laboratories Revenue Growth Rate in Biosimilar Testing and Development Services Business (2018-2023)
Figure 50. Pharmaceutical Product Development Revenue Growth Rate in Biosimilar Testing and Development Services Business (2018-2023)
Figure 51. Exova Revenue Growth Rate in Biosimilar Testing and Development Services Business (2018-2023)
Figure 52. Source BioScience Revenue Growth Rate in Biosimilar Testing and Development Services Business (2018-2023)
Figure 53. Intertek Group Revenue Growth Rate in Biosimilar Testing and Development Services Business (2018-2023)
Figure 54. Medistri Revenue Growth Rate in Biosimilar Testing and Development Services Business (2018-2023)
Figure 55. Pace Analytical Services Revenue Growth Rate in Biosimilar Testing and Development Services Business (2018-2023)
Figure 56. Sigma-Aldrich Revenue Growth Rate in Biosimilar Testing and Development Services Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed